ArticleRheumatology (Oxford, England)2023

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis.

Alessandro Tomelleri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.